Ethionamide-induced gynecomastia

Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixit, Ramakant, George, Jacob, Sharma, Arun K., chhabra, Naveen, Jangir, Suresh K., Mishra, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356967/
https://www.ncbi.nlm.nih.gov/pubmed/22629101
http://dx.doi.org/10.4103/0976-500X.95532
Descripción
Sumario:Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.

Ejemplares similares